Please enable JavaScript to continue using this application.

Compare $BRKR vs $MRVI | Chartloom

Compare

$BRKR vs $MRVI

Bruker Corp · Maravai LifeSciences Holdings Inc

BRKR

Bruker Corp

MRVI

Maravai LifeSciences Holdings Inc

Compare $BRKR vs $MRVI

Comparing Bruker Corp and Maravai LifeSciences Holdings Inc

BRKRBruker Corp

MRVIMaravai LifeSciences Holdings Inc

BRKRBruker Corp

Market cap

$8.96B

P/E (TTM)

—

Forward P/E (NTM)

25.41x

Forward P/S (NTM)

2.43x

Rev growth (TTM)

1.6%

YTD performance

22.3%

52W performance

69.9%

FCF yield

0.7%

MRVIMaravai LifeSciences Holdings Inc

Market cap

$1.92B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

8.68x

Rev growth (TTM)

-3.3%

YTD performance

118.8%

52W performance

123.4%

FCF yield

-1.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BRKR

MRVI

Detailed metrics comparison

BRKR

Bruker Corp

MRVI

Maravai LifeSciences Holdings Inc

Market Cap

BRKR$8.96B

MRVI$1.92B

Enterprise Value

BRKR$10.60B

MRVI$2.03B

Price

BRKR$58.84

MRVI$7.44

P/E Ratio

BRKRN/A

MRVIN/A

P/S Ratio

BRKR2.56x

MRVI9.20x

EV/Sales

BRKR3.03x

MRVI9.71x

EV/EBITDA

BRKR19.99x

MRVI24.69x

P/B Ratio

BRKR4.05x

MRVI10.03x

P/FCF Ratio

BRKR138.23x

MRVIN/A

EV/FCF

BRKR163.54x

MRVI-57.75x

PEG Ratio

BRKRN/A

MRVIN/A

Forward P/E (NTM)

BRKR25.41x

MRVIN/A

Forward P/S (NTM)

BRKR2.43x

MRVI8.68x

Revenue (TTM)

BRKR$3.50B

MRVI$209M

Revenue Growth (YoY)

BRKR1.6%

MRVI-3.3%

Forward Rev Growth

BRKR4.0%

MRVI6.5%

Gross Margin (TTM)

BRKR47.7%

MRVI34.9%

Operating Margin (TTM)

BRKR0.0%

MRVI0.0%

EBITDA Margin (TTM)

BRKR15.1%

MRVI-10.4%

Net Margin (TTM)

BRKR-3.1%

MRVI-37.1%

FCF Margin (TTM)

BRKR1.9%

MRVI-16.8%

Net Income (TTM)

BRKR$-107M

MRVI$-77M

FCF (TTM)

BRKR$65M

MRVI$-35M

EPS (TTM)

BRKR-$0.70

MRVI-$0.52

ROE (TTM)

BRKR-293.0%

MRVI-3542.0%

ROA (TTM)

BRKR-115.0%

MRVI-1054.0%

ROIC (TTM)

BRKR-167.0%

MRVI-1572.0%

Cash

BRKR$185M

MRVI$70M

Debt

BRKR$1.82B

MRVI$177M

Net Cash/Debt

BRKR$-1.64B

MRVI$-107M

Current Ratio (TTM)

BRKR1.85x

MRVI4.05x

Quick Ratio (TTM)

BRKR0.88x

MRVI2.63x

Debt/Equity (TTM)

BRKR0.77x

MRVI0.86x

Debt/Assets (TTM)

BRKR0.0%

MRVI0.0%

Interest Coverage (TTM)

BRKRN/A

MRVIN/A

Net Debt/EBITDA (TTM)

BRKR0.00x

MRVI0.00x

Beta

BRKR1.24

MRVI0.63

52W Performance

BRKR69.9%

MRVI123.4%

YTD Performance

BRKR22.3%

MRVI118.8%

% from 52W High

BRKR-12.2%

MRVI-21.0%

% from 52W Low

BRKR81.8%

MRVI192.3%

Asset Turnover (TTM)

BRKR0.56x

MRVI0.28x

FCF Yield (TTM)

BRKR0.7%

MRVI-1.8%

Earnings Yield (TTM)

BRKR-1.2%

MRVI-4.0%

Dividend Yield (TTM)

BRKR0.6%

MRVIN/A

Rule of 40

BRKR3.5

MRVI-20.1

EV/GP/RG

BRKR1.17

MRVI4.63

Ticker research

View BRKR research View MRVI research

Metric	BRKR Bruker Corp	MRVI Maravai LifeSciences Holdings Inc
Market & Valuation
Market Cap	$8.96B	$1.92B
Enterprise Value	$10.60B	$2.03B
Price	$58.84	$7.44
P/E Ratio	N/A	N/A
P/S Ratio	2.56x	9.20x
EV/Sales	3.03x	9.71x
EV/EBITDA	19.99x	24.69x
P/B Ratio	4.05x	10.03x
P/FCF Ratio	138.23x	N/A
EV/FCF	163.54x	-57.75x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	25.41x	N/A
Forward P/S (NTM)	2.43x	8.68x
Revenue & Growth
Revenue (TTM)	$3.50B	$209M
Revenue Growth (YoY)	1.6%	-3.3%
Forward Rev Growth	4.0%	6.5%
Profitability
Gross Margin (TTM)	47.7%	34.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	15.1%	-10.4%
Net Margin (TTM)	-3.1%	-37.1%
FCF Margin (TTM)	1.9%	-16.8%
Net Income (TTM)	$-107M	$-77M
FCF (TTM)	$65M	$-35M
EPS (TTM)	-$0.70	-$0.52
ROE (TTM)	-293.0%	-3542.0%
ROA (TTM)	-115.0%	-1054.0%
ROIC (TTM)	-167.0%	-1572.0%
Financial Health
Cash	$185M	$70M
Debt	$1.82B	$177M
Net Cash/Debt	$-1.64B	$-107M
Current Ratio (TTM)	1.85x	4.05x
Quick Ratio (TTM)	0.88x	2.63x
Debt/Equity (TTM)	0.77x	0.86x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.24	0.63
52W Performance	69.9%	123.4%
YTD Performance	22.3%	118.8%
% from 52W High	-12.2%	-21.0%
% from 52W Low	81.8%	192.3%
Efficiency & Yields
Asset Turnover (TTM)	0.56x	0.28x
FCF Yield (TTM)	0.7%	-1.8%
Earnings Yield (TTM)	-1.2%	-4.0%
Dividend Yield (TTM)	0.6%	N/A
Other
Rule of 40	3.5	-20.1
EV/GP/RG	1.17	4.63
Ticker research	View BRKR research	View MRVI research

Valuation

P/S Ratio

BRKR

2.56x

MRVI

9.20x

EV/FCF

MRVI

-57.75x

BRKR

163.54x

Growth & revenue

Revenue Growth TTM

BRKR

1.6%

MRVI

-3.3%

Forward Revenue Growth

MRVI

6.5%

BRKR

4.0%

Profitability & performance

Gross Margin

BRKR

47.7%

MRVI

34.9%

ROE

BRKR

-293.0%

MRVI

-3542.0%

FCF Yield %

BRKR

0.7%

MRVI

-1.8%

52-Week Performance

MRVI

123.4%

BRKR

69.9%

Detailed metrics comparison

BRKR

Bruker Corp

MRVI

Maravai LifeSciences Holdings Inc

Market Cap

BRKR$8.96B

MRVI$1.92B

Enterprise Value

BRKR$10.60B

MRVI$2.03B

Price

BRKR$58.84

MRVI$7.44

P/E Ratio

BRKRN/A

MRVIN/A

P/S Ratio

BRKR2.56x

MRVI9.20x

EV/Sales

BRKR3.03x

MRVI9.71x

EV/EBITDA

BRKR19.99x

MRVI24.69x

P/B Ratio

BRKR4.05x

MRVI10.03x

P/FCF Ratio

BRKR138.23x

MRVIN/A

EV/FCF

BRKR163.54x

MRVI-57.75x

PEG Ratio

BRKRN/A

MRVIN/A

Forward P/E (NTM)

BRKR25.41x

MRVIN/A

Forward P/S (NTM)

BRKR2.43x

MRVI8.68x

Revenue (TTM)

BRKR$3.50B

MRVI$209M

Revenue Growth (YoY)

BRKR1.6%

MRVI-3.3%

Forward Rev Growth

BRKR4.0%

MRVI6.5%

Gross Margin (TTM)

BRKR47.7%

MRVI34.9%

Operating Margin (TTM)

BRKR0.0%

MRVI0.0%

EBITDA Margin (TTM)

BRKR15.1%

MRVI-10.4%

Net Margin (TTM)

BRKR-3.1%

MRVI-37.1%

FCF Margin (TTM)

BRKR1.9%

MRVI-16.8%

Net Income (TTM)

BRKR$-107M

MRVI$-77M

FCF (TTM)

BRKR$65M

MRVI$-35M

EPS (TTM)

BRKR-$0.70

MRVI-$0.52

ROE (TTM)

BRKR-293.0%

MRVI-3542.0%

ROA (TTM)

BRKR-115.0%

MRVI-1054.0%

ROIC (TTM)

BRKR-167.0%

MRVI-1572.0%

Cash

BRKR$185M

MRVI$70M

Debt

BRKR$1.82B

MRVI$177M

Net Cash/Debt

BRKR$-1.64B

MRVI$-107M

Current Ratio (TTM)

BRKR1.85x

MRVI4.05x

Quick Ratio (TTM)

BRKR0.88x

MRVI2.63x

Debt/Equity (TTM)

BRKR0.77x

MRVI0.86x

Debt/Assets (TTM)

BRKR0.0%

MRVI0.0%

Interest Coverage (TTM)

BRKRN/A

MRVIN/A

Net Debt/EBITDA (TTM)

BRKR0.00x

MRVI0.00x

Beta

BRKR1.24

MRVI0.63

52W Performance

BRKR69.9%

MRVI123.4%

YTD Performance

BRKR22.3%

MRVI118.8%

% from 52W High

BRKR-12.2%

MRVI-21.0%

% from 52W Low

BRKR81.8%

MRVI192.3%

Asset Turnover (TTM)

BRKR0.56x

MRVI0.28x

FCF Yield (TTM)

BRKR0.7%

MRVI-1.8%

Earnings Yield (TTM)

BRKR-1.2%

MRVI-4.0%

Dividend Yield (TTM)

BRKR0.6%

MRVIN/A

Rule of 40

BRKR3.5

MRVI-20.1

EV/GP/RG

BRKR1.17

MRVI4.63

Ticker research

View BRKR research View MRVI research

Metric	BRKR Bruker Corp	MRVI Maravai LifeSciences Holdings Inc
Market & Valuation
Market Cap	$8.96B	$1.92B
Enterprise Value	$10.60B	$2.03B
Price	$58.84	$7.44
P/E Ratio	N/A	N/A
P/S Ratio	2.56x	9.20x
EV/Sales	3.03x	9.71x
EV/EBITDA	19.99x	24.69x
P/B Ratio	4.05x	10.03x
P/FCF Ratio	138.23x	N/A
EV/FCF	163.54x	-57.75x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	25.41x	N/A
Forward P/S (NTM)	2.43x	8.68x
Revenue & Growth
Revenue (TTM)	$3.50B	$209M
Revenue Growth (YoY)	1.6%	-3.3%
Forward Rev Growth	4.0%	6.5%
Profitability
Gross Margin (TTM)	47.7%	34.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	15.1%	-10.4%
Net Margin (TTM)	-3.1%	-37.1%
FCF Margin (TTM)	1.9%	-16.8%
Net Income (TTM)	$-107M	$-77M
FCF (TTM)	$65M	$-35M
EPS (TTM)	-$0.70	-$0.52
ROE (TTM)	-293.0%	-3542.0%
ROA (TTM)	-115.0%	-1054.0%
ROIC (TTM)	-167.0%	-1572.0%
Financial Health
Cash	$185M	$70M
Debt	$1.82B	$177M
Net Cash/Debt	$-1.64B	$-107M
Current Ratio (TTM)	1.85x	4.05x
Quick Ratio (TTM)	0.88x	2.63x
Debt/Equity (TTM)	0.77x	0.86x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.24	0.63
52W Performance	69.9%	123.4%
YTD Performance	22.3%	118.8%
% from 52W High	-12.2%	-21.0%
% from 52W Low	81.8%	192.3%
Efficiency & Yields
Asset Turnover (TTM)	0.56x	0.28x
FCF Yield (TTM)	0.7%	-1.8%
Earnings Yield (TTM)	-1.2%	-4.0%
Dividend Yield (TTM)	0.6%	N/A
Other
Rule of 40	3.5	-20.1
EV/GP/RG	1.17	4.63
Ticker research	View BRKR research	View MRVI research